Lilith Hayakawa Mist Executive Clinical Research Director
Merck
Lilith Hayakawa Mist is an innovative servant-leader who has dedicated her professional life to excellence in the conduct of clinical trials. She has over 23 years experience delivering complex projects in a wide range of therapeutic areas. Passionate about increasing access to clinical trials, she is leading initiatives to increase clinical trial awareness, deepen community engagement, and maintain monitoring oversight during times of disruption. As Executive Director, Global Clinical Trial Operations, she oversees US ID & Vaccine trial operations for Merck.